Mark J Gergen Insider Trading $MYG Mirati Therapeutics, Inc.
Get free email notifications about insider trading for Mark J Gergen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark J Gergen. Mark J Gergen is Sr VP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Operating Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Executive VP, COO in Mirati Therapeutics, Inc. ($MYG) and President and CBO in Poseida Therapeutics, Inc. ($PSTX).
Mark J Gergen in Mirati Therapeutics, Inc.
Trading Symbol: MYGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Gergen: Executive VP, COO
Holdings: 5,748 shares
Latest Transaction: Jan 26 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark J Gergen in Mirati Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMLN, GYHT, MYG, PSTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | A | 24.99 | 60,000 | 1,499,400 | 60,000 | |
Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 10,000 | 85,000 | 117,000 | |
Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 5,000 | 42,500 | 127,000 | |
Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Sell | S | 25.92 | 10,000 | 259,211 | 5,748 | 15.7 K to 5.7 K (-63.50 %) |
Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Buy | M | 8.50 | 10,000 | 85,000 | 15,748 | 5.7 K to 15.7 K (+173.97 %) |
Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Buy | M | 8.50 | 5,000 | 42,500 | 5,748 | 748 to 5.7 K (+668.45 %) |
Page: 1